Aesthetic Adherence in Lifestyle Medicine: An Arts-Informed Translational Framework for Cardiometabolic Prevention and Patient Activation in Medical Settings
Background: Cardiometabolic disease remains a dominant medical and public health challenge. Although clinical guidelines increasingly converge around lifestyle medicine, preventive cardiometabolic care is frequently limited by low adherence, insufficient health literacy, fragmented motivation, and the emotional distance between medical advice and lived daily behavior. Arts and cultural engagement have been associated with health promotion, social connection, stress regulation, patient meaning-making, and potentially relevant biological pathways. However, the medical literature still lacks practical frameworks that translate arts-informed methods into primary care, occupational health, and community prevention without overclaiming efficacy.
Objective: This narrative review proposes Aesthetic Adherence, an arts-informed translational framework designed to improve patient activation, health literacy, and adherence to lifestyle medicine for cardiometabolic prevention. Methods: Evidence from cardiometabolic prevention, health literacy, adherence science, behavior-change theory, social prescribing, arts and health, narrative medicine, patient-clinician communication, and implementation science was narratively integrated.
Results: The proposed ART-ADHERE framework includes eight operational components: Aesthetic attention, Relational trust, Translation of evidence into symbols, Affective self-regulation, Daily micro rituals, Health-literacy co-creation, Ecological support, and Reflective evaluation. The framework is positioned as an adjunctive clinical and community strategy, not as a substitute for evidence-based medical treatment, nutrition, physical activity, pharmacotherapy, or risk-factor control.
Conclusion: Aesthetic Adherence may help bridge the persistent gap between knowing and doing in cardiometabolic prevention by making lifestyle prescriptions more meaningful, memorable, relational, and behaviorally actionable. Future pragmatic trials should evaluate feasibility, acceptability, equity, adherence, clinical biomarkers, and cost-effectiveness.